Melanoma: Pattern Analysis & Diagnosis
Multicomponent asymmetric architecture, atypical network, blue-white veil, regression, and atypical vessels define the dermoscopic vocabulary of cutaneous melanoma.
In brief
Melanoma displays a characteristic disorganization that dermoscopy uncovers before the naked eye recognizes it. The diagnostic strategy combines two layers: a global pattern (typically multicomponent and asymmetric) and a roster of local features that map to specific histopathologic events at the dermoepidermal junction or within the dermis. Three meta-analyses and two randomized trials confirm that dermoscopy raises sensitivity for melanoma from approximately 74% (naked eye) to 90% without loss of specificity.
Clinical content
01Superficial spreading melanoma (SSM) is the archetype that anchors most dermoscopic teaching. Junctional features (atypical network, irregular dots, irregular globules, irregular streaks/pseudopods, irregular blotches) reflect heterogeneous melanocytic nests at the dermoepidermal junction. Mixed junctional-dermal features (regression structures, negative network, white shiny streaks) reflect the regression process and dermal fibrosis. Dermal features (blue-white veil, atypical vessels) signal invasion. Most early SSMs display a multicomponent global pattern, but a subset of in situ tumors still show a reticular or globular pattern with subtle asymmetry.
02Nodular melanoma lacks the junctional vocabulary because the tumor invades the dermis from the outset. Three criteria carry the diagnosis: blue-black coloration (simultaneous blue and black within a single lesion not explained by comedo-like openings or vascular lacunas), atypical vascular pattern (linear-irregular vessels, polymorphic vessels, or more than two vessel types), and milky-red structureless pink. Any nodular lesion that cannot be confidently classified should be excised; nodular melanoma kills disproportionately because diagnosis is delayed.
03Lentigo maligna and acral lentiginous melanoma require site-specific frameworks because the dermoepidermal junction is anatomically flattened (face) or elaborated into ridges and furrows (palms and soles). Network is rarely seen on the face; instead, lentigo maligna features develop around the follicular openings (asymmetric pigmented follicles, gray dots, gray circles, rhomboidal structures, target-like patterns). On acral skin, the parallel ridge pattern (pigment on ridges) discriminates from the parallel furrow pattern (pigment in furrows) of nevi.
04Atypical pigment network is heterogeneous in line thickness, hole size, and color across the lesion. It corresponds to irregular and broadened rete ridges with uneven nest distribution. The thin and uniform network of benign nevi contrasts with the broadened and abruptly ending network of melanoma. Atypical network was the most frequent SSM feature historically, but recent in-situ data suggest that irregular hyperpigmented areas and prominent skin markings may be more sensitive in early lesions.
05Blue-white veil is an irregularly shaped blotch of blue color with overlying white ground-glass haze. Histopathologically it represents acanthotic epidermis with focal hypergranulosis above sheets of heavily pigmented dermal melanocytes. With non-polarized dermoscopy the veil appears as a confluent blue-white area; with polarized light the same anatomy presents as blue structureless color plus white shiny strands. Blue-white veil signals dermal invasion and correlates with tumor thickness over 0.8 mm.
06Regression structures take two forms. Blue-gray peppering (free melanin and melanophages in the upper dermis) marks active regression and can occur in melanoma, regressing nevi, and lichen planus-like keratosis. Scar-like white depigmentation (dermal fibrosis) marks completed regression and is unusual in benign lesions outside dermatofibromas. Extensive regression occupying more than half a lesion is suggestive but not pathognomonic; the regression-with-melanoma-features rule (regression plus any other melanoma criterion) reliably triggers excision.
07Atypical vessels in melanoma are polymorphic. The most informative are linear-irregular vessels (vessels with multiple kinks and bends), corkscrew vessels (looped vessels twisted around an axis), and the combination of dotted plus short linear vessels in flat amelanotic lesions. The presence of more than one vessel morphology in a solitary lesion is itself a melanoma cue. Milky-red areas (structureless pink) often coexist with atypical vessels and signal angiogenesis in vertical-growth-phase tumors.
08Amelanotic and hypomelanotic melanoma lacks pigment-based criteria, forcing reliance on vessel morphology. Polymorphic vessels (multiple morphologies in one lesion), milky-red areas, white shiny structures, and residual pink-red coloration on a lesion arising in light skin warrant excision. Roughly 10% of melanomas are amelanotic or hypomelanotic, and these account for a disproportionate share of missed diagnoses.
09Sequential dermoscopy and the evolution criterion (E in ABCDE) capture melanomas that lack baseline diagnostic features. Argenziano's monitoring data showed that 7 of 12 melanomas detected during follow-up appeared after 8 to 54 months, supporting both short-term (3-month) monitoring for highly suspicious lesions and long-term annual monitoring for slow-growing tumors. Any change in size, color, or structure on a flat melanocytic lesion in an adult is a hard indication for excision.
Key dermoscopic features
High yield clinical points15 pearls in 5 groups
Recognition & pattern analysis
5 pointsDiagnostic criteria & thresholds
4 pointsPitfalls & mimics
1 pointWhen to biopsy
3 pointsFollow-up & monitoring
2 pointsLectures covering this topic19 lectures
Notable updates & conceptual milestones7 updates
Three meta-analyses confirming dermoscopy benefit
2008Bafounta 2001, Kittler 2002, and Vestergaard 2008 collectively established that dermoscopy raises melanoma sensitivity by 14-19% over naked eye in clinical settings without specificity loss, ending two decades of debate.
Pattern analysis (Pehamberger 1987)
1987The original method that defined dermoscopic criteria and remains the reference standard against which all later algorithms are validated.
Seven-point checklist (Argenziano 1998)
1998Three major (atypical network, blue-white veil, atypical vascular pattern) and four minor criteria (irregular streaks, irregular pigmentation, irregular dots/globules, regression structures) with a simple scoring system. Performs comparably to ABCD with greater simplicity.
Irregular hyperpigmented areas for melanoma in situ
2018Lallas 2018 demonstrated that classical criteria undercall in-situ lesions and that irregular hyperpigmented areas plus prominent skin markings are the strongest in-situ predictors, prompting an update to the melanoma-criterion list.
Sequential dermoscopic imaging protocols
2008Short-term (3-month) versus long-term (annual) monitoring strategies, with documented melanoma detection rates around 3% in patients with multiple atypical nevi and improved patient compliance for short-term protocols.
AI dermoscopy meta-analysis (38 studies)
2025A 2025 meta-analysis pooling AI dermoscopy across 38 studies reported sensitivity 0.86 and specificity 0.94 for melanoma detection, comparable to dermatologists. Dataset selection bias inflates real-world expectations and AI is best positioned as a second reader.
3D total-body photography RCT
2025A 2025 randomized trial showed 3D total-body photography with teledermatology review in high-risk patients did not reduce melanoma incidence and increased per-person biopsy rates compared with usual care, indicating imaging without AI triage can drive overcalling.
Bottom line
Multicomponent asymmetric architecture, atypical network, blue-white veil, regression, and atypical vessels define the dermoscopic vocabulary of cutaneous melanoma.
15 clinical points · 7 recent updates · 13 references
Source content
AAD 2026 · U004 · #03
Dermoscopy to the Rescue: Melanoma
Kelly C. Nelson, MD, FAAD · MD Anderson Cancer Center, Houston, Texas
AAD 2026 · F036 · #02
Melanoma and its Mimics
Kelly C. Nelson, MD, FAAD · MD Anderson Cancer Center, Houston, Texas
AAD 2026 · F042 · #01
Invasive vs In Situ Melanomas
Konstantinos Liopyris, MD, PhD · AAD 2026 Dermoscopy Symposium
AAD 2026 · S001 · #01
Dermatoscopy of Melanoma
Dawn Hirokawa, MD, MPH · Mass General Brigham
References
Sources cited in the lecture content or that underpin the clinical points above. Verify with primary sources before practice changes.
- [1]Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions, a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001;2:443-449.PubMed: 11905739DOI: 10.1016/S1470-2045(00)00422-8· Synthesis of pattern analysis, ABCD, Menzies, and 7-point methods plus follow-up principles.
- [2]Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008;159:669-676.PubMed: 18616769DOI: 10.1111/j.1365-2133.2008.08713.x· Definitive meta-analysis quantifying dermoscopy's incremental sensitivity.
- [3]Lallas A, Longo C, Manfredini M, et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol 2018;154:414-419.PubMed: 29466542DOI: 10.1001/jamadermatol.2017.6447· Demonstrated that irregular hyperpigmented areas and prominent skin markings are the strongest in-situ predictors.
- [4]Carrera C, Marchetti MA, Dusza SW, et al. Validity and reliability of dermoscopic criteria used to differentiate nevi from melanoma: a Web-based International Dermoscopy Society study. JAMA Dermatol 2016;152:798-806.PubMed: 27074267DOI: 10.1001/jamadermatol.2016.0624· Architectural disorder and asymmetry outperform individual local features in reliability and discriminatory power.
- [5]Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48:679-693.PubMed: 12734496DOI: 10.1067/mjd.2003.281· Standardized criteria and the two-step diagnostic algorithm used worldwide.
- [6]Kittler H, Marghoob AA, Argenziano G, et al. Standardization of terminology in dermoscopy/dermatoscopy: results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol 2016;74:1093-1106.PubMed: 26896294DOI: 10.1016/j.jaad.2015.12.038· Authoritative source for dermoscopic terminology used in the criteria descriptions.
- [7]Argenziano G, Mordente I, Ferrara G, Sgambato A, Annese P, Zalaudek I. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008;159:331-336.PubMed: 18510663DOI: 10.1111/j.1365-2133.2008.08649.x· Empirical basis for short-term versus long-term monitoring protocols.
- [8]Nadour N, Duguet T, Zahedi S, et al. Diagnostic accuracy of artificial intelligence compared to family physicians and dermatologists for skin conditions: a systematic review and meta-analysis. BMC Prim Care. 2025;26(1):384.PubMed: 41315984DOI: 10.1186/s12875-025-03073-9· Meta-analysis of 38 studies; AI dermoscopy sensitivity 0.86 and specificity 0.94 for melanoma detection.
- [9]Soyer HP, Jayasinghe D, Rodriguez-Acevedo AJ, et al. 3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial. JAMA Dermatol. 2025;161(5):472-481.PubMed: 40136310DOI: 10.1001/jamadermatol.2025.0211· RCT of 3D-TBP plus teledermatology in high-risk patients did not reduce melanoma incidence and increased biopsy rate.
- [10]Lindsay D, Soyer HP, Janda M, et al. Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma. JAMA Dermatol. 2025;161(5):482-489.PubMed: 40136266DOI: 10.1001/jamadermatol.2025.0219· Cost-effectiveness companion: extra US$945 per person over two years with no QALY gain, supporting selective use.
- [11]Varga NN, Gulyas L, Meznerics FA, et al. Diagnostic Accuracy of Novel Optical Imaging Techniques for Melanoma Detection: A Systematic Review and Meta-Analysis. Int J Dermatol. 2025;64(10):1813-1824.PubMed: 40339039DOI: 10.1111/ijd.17828· Meta-analysis of 138 studies positioning RCM and AI-augmented dermoscopy as second-step evaluation; AI plus dermoscopy sensitivity 0.93, specificity 0.77.
- [12]Musolff N, Tchack M, Chaudhry ZS, Sanabria B, Rao B. Updates in Dermoscopy for Pigmented Lesions. Dermatol Clin. 2025;43(3):419-432.PubMed: 40581422DOI: 10.1016/j.det.2025.03.009· 2025 review consolidating modern pigmented-lesion algorithms (ABCDE, 7-point, ASAP) with newer pattern criteria.
- [13]Zboraș I, Ungureanu L, Șenilă SC, et al. Comparative Dermoscopic Analysis of Melanoma In Situ Versus Thin Invasive Melanoma Considering BRAF Mutational Status. J Clin Med. 2025;14(18):6554.PubMed: 41010758DOI: 10.3390/jcm14186554· Five features (irregular dots and globules, blue-white veil, milky red areas, dotted vessels, linear irregular vessels) distinguish thin invasive from in situ; BRAF status not predictable from dermoscopy.